Assessment of exhaled breath condensate pH.

Exhaled breath condensates: analyzing the expiratory plume. Am J Respir Crit Care Med (2012) 1.45

Why conventional exhaled breath condensate pH studies cannot provide reliable estimates of airway acidification. Chest (2011) 0.75

Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: A longitudinal study. Am J Respir Crit Care Med (2010) 1.82

Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 8.66

Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest (2007) 5.01

An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med (2013) 4.49

A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med (2016) 3.99

Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med (2014) 3.51

A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest (2013) 2.71

Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab (2004) 2.47

Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.97

Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med (2003) 1.93

Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1.91

Coronary artery and thoracic calcium on noncontrast thoracic CT scans: comparison of ungated and gated examinations in patients from the COPD Gene cohort. J Cardiovasc Comput Tomogr (2010) 1.91

The effects of volatile salivary acids and bases on exhaled breath condensate pH. Am J Respir Crit Care Med (2005) 1.85

Methodology for using long-term accelerometry monitoring to describe daily activity patterns in COPD. COPD (2009) 1.79

Indicator dilution measurements of extravascular lung water: basic assumptions and observations. Am J Physiol Lung Cell Mol Physiol (2008) 1.74

An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.73

A treadmill ramp protocol using simultaneous changes in speed and grade. Med Sci Sports Exerc (2003) 1.69

Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy. Am J Respir Crit Care Med (2014) 1.68

Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab (2003) 1.57

Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc (2007) 1.56

Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab (2002) 1.54

Skeletal muscle mRNA for IGF-IEa, IGF-II, and IGF-I receptor is decreased in sedentary chronic hemodialysis patients. Kidney Int (2005) 1.51

Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone. Am J Physiol Lung Cell Mol Physiol (2009) 1.50

Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema. Thorax (2014) 1.48

Exhaled breath condensates: analyzing the expiratory plume. Am J Respir Crit Care Med (2012) 1.45

Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. Chest (2002) 1.45

Counterpoint: Is an increase in FEV₁ and/or FVC ≥ 12% of control and ≥ 200 mL the best way to assess positive bronchodilator response? No. Chest (2014) 1.42

Sinusoidal high-intensity exercise does not elicit ventilatory limitation in chronic obstructive pulmonary disease. Exp Physiol (2013) 1.41

Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. Respir Med (2011) 1.41

Constant work rate exercise testing: a tricky measure of exercise tolerance. COPD (2009) 1.40

Physiologic effects of an ambulatory ventilation system in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.39

Developmental cell/molecular biologic approach to the etiology and treatment of bronchopulmonary dysplasia. Pediatr Res (2007) 1.36

Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men. J Clin Endocrinol Metab (2005) 1.28

Epithelial lining fluid solute concentrations in chronic obstructive lung disease patients and normal subjects. J Appl Physiol (1985) (2005) 1.25

Exercise in maintenance hemodialysis patients induces transcriptional changes in genes favoring anabolic muscle. J Am Soc Nephrol (2007) 1.21

Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest (2005) 1.19

Endurance exercise training during haemodialysis improves strength, power, fatigability and physical performance in maintenance haemodialysis patients. Nephrol Dial Transplant (2005) 1.19

Thirdhand smoke causes DNA damage in human cells. Mutagenesis (2013) 1.14

Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD. Respir Med (2010) 1.13

Clinical and radiographic correlates of hypoxemia and oxygen therapy in the COPDGene study. Respir Med (2011) 1.12

Evidence for in vivo nicotine-induced alveolar interstitial fibroblast-to-myofibroblast transdifferentiation. Exp Lung Res (2010) 1.09

Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model. Pediatr Res (2009) 1.09

Mechanism for nicotine-induced up-regulation of Wnt signaling in human alveolar interstitial fibroblasts. Exp Lung Res (2010) 1.08

Up-regulation of fetal rat lung parathyroid hormone-related protein gene regulatory network down-regulates the Sonic Hedgehog/Wnt/betacatenin gene regulatory network. Pediatr Res (2006) 1.07

Prevention and treatment of bronchopulmonary dysplasia: contemporary status and future outlook. Lung (2008) 1.06

Metabolic and morphometric profile of muscle fibers in chronic hemodialysis patients. J Appl Physiol (1985) (2011) 1.04

Deconvoluting lung evolution using functional/comparative genomics. Am J Respir Cell Mol Biol (2004) 1.04

Compartmentalization of stearoyl-coenzyme A desaturase 1 activity in HepG2 cells. J Lipid Res (2008) 1.04

Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients. Int J Chron Obstruct Pulmon Dis (2008) 1.01

PPARγ agonist rosiglitazone prevents perinatal nicotine exposure-induced asthma in rat offspring. Am J Physiol Lung Cell Mol Physiol (2011) 1.00

An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing Implementation, Use, and Delivery of Pulmonary Rehabilitation. Am J Respir Crit Care Med (2015) 1.00

Utility of exhaled breath condensates in chronic obstructive pulmonary disease: a critical review. Curr Opin Pulm Med (2005) 0.97

Skeletal muscle adaptations to testosterone and resistance training in men with COPD. J Appl Physiol (1985) (2007) 0.95

Leptin stimulates Xenopus lung development: evolution in a dish. Evol Dev (2009) 0.95

Effect of maternal food restriction on fetal rat lung lipid differentiation program. Pediatr Pulmonol (2009) 0.95

Characterization of a novel fibroblast growth factor 10 (Fgf10) knock-in mouse line to target mesenchymal progenitors during embryonic development. PLoS One (2012) 0.92

Oxygen-induced metabolic changes and transdifferentiation in immature fetal rat lung lipofibroblasts. Mol Genet Metab (2002) 0.91

A potential role of the JNK pathway in hyperoxia-induced cell death, myofibroblast transdifferentiation and TGF-β1-mediated injury in the developing murine lung. BMC Cell Biol (2011) 0.91

Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes? Ann Nutr Metab (2013) 0.91

Sex-specific perinatal nicotine-induced asthma in rat offspring. Am J Respir Cell Mol Biol (2012) 0.90

Pulmonary rehabilitation: WHAT WE KNOW AND WHAT WE NEED TO KNOW. J Cardiopulm Rehabil Prev (2009) 0.89

Effect of exercise on mRNA levels for growth factors in skeletal muscle of hemodialysis patients. J Ren Nutr (2006) 0.89

Curcumin augments lung maturation, preventing neonatal lung injury by inhibiting TGF-β signaling. Am J Physiol Lung Cell Mol Physiol (2011) 0.88

Allergic inflammation in the human lower respiratory tract affected by exposure to diesel exhaust. Res Rep Health Eff Inst (2012) 0.88

Effect of hyperoxia on gas exchange and lactate kinetics following exercise onset in nonhypoxemic COPD patients. Chest (2002) 0.87

Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease. Clin Infect Dis (2012) 0.86

Deconvoluting lung evolution: from phenotypes to gene regulatory networks. Integr Comp Biol (2007) 0.85

Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease. Ann Am Thorac Soc (2014) 0.84

Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization. COPD (2011) 0.83

Postnatal rosiglitazone administration to neonatal rat pups does not alter the young adult metabolic phenotype. Neonatology (2011) 0.83

Comment on 'the effect of temperature on exhaled breath condensate collection'. J Breath Res (2012) 0.82

Prenatal rosiglitazone administration to neonatal rat pups does not alter the adult metabolic phenotype. PPAR Res (2012) 0.82

Reduction of hyperinflation by pharmacologic and other interventions. Proc Am Thorac Soc (2006) 0.81

Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy. COPD (2012) 0.81

Breath-by-breath quantification of progressive airflow limitation during exercise in COPD: a new method. Respir Med (2010) 0.81

Stewart approach is not always a practical clinical tool. Anesth Analg (2004) 0.81

Testosterone and resistance training effects on muscle nitric oxide synthase isoforms in COPD men. Respir Med (2011) 0.80

Do low exhaled condensate NH4+ concentrations in asthma reflect reduced pulmonary production? Am J Respir Crit Care Med (2003) 0.79

Exhaled breath condensate: delusion or dilution? Chest (2010) 0.79

Saving the breath condensate approach. Am J Respir Crit Care Med (2003) 0.79

Pulmonary rehabilitation for COPD. Respir Med (2005) 0.79

Perfluorooctane sulfonate disturbs Nanog expression through miR-490-3p in mouse embryonic stem cells. PLoS One (2013) 0.78

Interpreting results from clinical trials: understanding minimal clinically important differences in COPD outcomes. COPD (2005) 0.78

Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2014) 0.78

Increased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients. BMC Pulm Med (2014) 0.78

Supervised high intensity continuous and interval training vs. self-paced training in COPD. Respir Med (2007) 0.78

Mitochondrial disorders and exertional intolerance: controversy continues. Am J Respir Crit Care Med (2002) 0.77

Exhaled breath condensate pH. Am J Respir Crit Care Med (2006) 0.77

The effect of inhaled nitric oxide and oxygen on the hydroxylation of salicylate in rat lungs. Pediatr Res (2003) 0.77